Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.400
+0.040 (1.69%)
At close: Aug 21, 2026, 4:00 PM EDT
2.381
-0.019 (-0.77%)
After-hours: Aug 21, 2026, 7:45 PM EDT

Compass Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
432955200199633309
Market Cap Growth
-9.38%378.75%0.34%-68.61%105.02%-
Enterprise Value
2627457137516292
Last Close Price
2.405.371.451.565.033.17

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--234.71---
PB Ratio
2.604.851.591.343.492.21
P/TBV Ratio
2.604.851.591.343.492.21

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--83.51---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.060.050.050.010.020.03
Net Debt / Equity Ratio
-1.02-1.01-0.96-1.01-1.01-1.00
Net Debt / EBITDA Ratio
2.102.742.143.044.494.58
Net Debt / FCF Ratio
3.024.052.683.715.356.52
Asset Turnover
--0.01---
Quick Ratio
11.1514.9614.2819.5411.5413.59
Current Ratio
11.2215.0214.9619.7312.0513.84
Return on Equity (ROE)
-56.66%-41.29%-36.07%-25.74%-24.39%-91.30%
Return on Assets (ROA)
-33.03%-25.29%-23.81%-17.66%-14.73%-19.00%
Return on Capital Employed (ROCE)
-46.60%-35.40%-43.10%-33.80%-22.70%-21.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-16.99%-6.96%-24.75%-21.37%-6.19%-26.60%
FCF Yield
-13.04%-5.15%-22.50%-20.44%-5.42%-6.98%
Buyback Yield / Dilution
-31.82%-14.78%-8.15%-20.76%-67.31%-104.28%
SEC Filings: 10-K · 10-Q